Starbucks is pulling back coverage for weight-loss drugs, a reversal that comes as employers’ spending on popular GLP-1 medicines soars.
Starting in October, the Seattle-based coffee chain’s health plans will no longer cover GLP-1 medications prescribed for weight loss for benefits-eligible employees, though the drugs may still be covered for other conditions. Starbucks offers health benefits to full- and part-time employees who work at least 20 hours a week.
A spokesperson for Starbucks confirmed the decision, which hasn’t previously been reported, and declined to comment further.
Starbucks’ move reflects a broader recalibration of a benefit…
